SOPHARMA AD (114/2026) Publishing of Annual individual audited financial statement for 2025

Podstawa prawna: Art. 56. 1. 2 of Act on Public Offering

Sofia, Bulgaria, 30 March 2026 - According to the requirements of art. 100n of LPOS, "Sopharma" AD (SFA: "BSE-Sofia" AD, SPH: Warsaw Stock Exchange) presents the Annual Audited Individual Financial Statements, which contains:

- XHTML format of the report in accordance with the requirements of Commission Delegated Regulation (EU) 2018/815 of 17 December 2018 supplementing Directive 2004/109/EC of the European Parliament and of the Council with regulatory technical standards on the definition of a common electronic format for reports. It contains:

- Annual financial statements according to IFRS;

- Notes to the annual financial statements;

- Annual management report and non-financial declaration;

- Corporate governance Declaration;

- Report on the implementation of the remuneration policy;

- Declaration by the responsible persons;

- Audit report; and

- Audit declaration.

- Annual reports according to a template determined by the Deputy Chairman of the Financial Supervision Commision;

- Corporate Governance Scorecard;

- Electronic reference to the published inside information under Article 7 of Regulation (EU) ą596 / 2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (OJ L 173/1 of 12 June 2014) (Regulation (EU) ą 596/2014) on the circumstances during the past year:

http://www.x3news.com/?page=News_uniqid=6242d3eba9dc7

https://www.sopharmagroup.com/en/home/investors/investor-news/public-disclosure-of-inside-information-in-compliance-with-article-17-of-regulation-eu-no-596-2014-on-market-abuse

Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1